A new subvariant of COVID-19, officially identified as BA.3.2 and informally referred to as the "Cicada" variant, has been detected through genomic and wastewater surveillance in over 23 countries, including the United States, the UK, and India.
While the sudden emergence of a new strain has sparked discussions online, health experts and global agencies are urging the public to remain calm while they monitor its transmission patterns.
Why is it Called the "Cicada" Variant?
The BA.3.2 subvariant belongs to the Omicron family, specifically descending from the older BA.3 lineage that largely disappeared in 2022.
Researchers informally nicknamed it "Cicada" because of its unusual evolutionary path. Much like the insect that stays underground for years before suddenly emerging, this variant was first detected in South Africa in November 2024 but remained dormant and undetected for over a year before recently surging on the global stage.
What Makes BA.3.2 Different?
The defining feature of BA.3.2 is its unusually high number of mutations.
• High Mutation Count: The variant carries approximately 70 to 75 mutations in its spike protein.
• Immune Evasion: Because of these genetic changes, early clinical data suggests that BA.3.2 is highly adept at evading antibodies. This means it can partially bypass the immunity provided by prior infections or the current updated COVID-19 vaccines.
• Variant Under Monitoring: Due to its heavily mutated profile, the World Health Organization (WHO) officially classified BA.3.2 as a "Variant Under Monitoring" (VUM) in December 2025.
Current Risk Level and Symptoms
Despite its ability to spread and evade immunity, the current public health risk remains manageable.
There is no confirmed evidence indicating that the Cicada variant causes more severe illness, higher hospitalization rates, or different symptoms than previous Omicron strains. Symptoms remain standard, presenting as a respiratory infection with fever, cough, congestion, fatigue, and occasional gastrointestinal issues.
While the variant accounts for up to 30% of new sequences in parts of Europe (such as Denmark and Germany), it has not rapidly overtaken other dominant variants worldwide.
Conclusion
The BA.3.2 "Cicada" variant serves as a reminder of the virus's ability to mutate and evolve. Authorities continue to advise standard precautions, noting that while the variant is highly mutated, current antiviral treatments and foundational vaccine immunity still protect against severe disease. There is currently no cause for panic, though genomic surveillance remains active.
Key Points
• Limited but Growing Spread: Detected in 23+ countries and 25+ U.S. states, largely identified through wastewater tracking.
• Highly Mutated: Features 70–75 spike protein mutations, allowing for notable immune escape.
• No Elevated Severity: No evidence of increased severity or higher hospitalization rates compared to existing strains.
• Under Official Monitoring: Classified as a Variant Under Monitoring (VUM) by the WHO.
Follow us for more updates
covid ba3.2 cicada variant, new covid variant 2026, covid subvariant cicada symptoms, omicron sublineage ba3.2, covid cases global update, WHO covid variant news, CDC covid update, highly mutated covid strain
Post a Comment
If you have any doubts, Please let me know